Clinical trial
A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second…
NCT00164931 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00164931 |
|---|---|
| Title | A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer |
| Official title | Phase 3 Study of Prospective Randomized Trial Comparing Adjunctive High Dose Omeprazole Infusion Against Scheduled Second Endoscopy in the Prevention of Peptic Ulcer Rebleeding After Therapeutic Endoscopy |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Peptic Ulcer Hemorrhage |
| Intervention type | Drug, Procedure |
| Interventions | Intravenous omeprazole infusion, Scheduled second endoscopy |
| Enrollment | 240 |
| Start date | Oct 1, 2003 |
| First posted | Sep 14, 2005 |
| Last update posted | Jun 10, 2011 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: